Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors

Molecular Pharmacology

Volumn 79, Issue 5, 2011, Pages 886-893

  Zhou, Yongchun ^a   Rajabi, Hasan ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; BAICALEIN; DIMER; MESSENGER RNA; MUCIN 1; ONCOPROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DIMERIZATION; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUC1 GENE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; APIGENIN; CELL LINE, TUMOR; CELL SURVIVAL; DIMERIZATION; DOWN-REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; MUCIN-1; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79954996475     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.070797     Document Type: Article

References (35)

1. Ahmad R, Raina D, Joshi MD, Kawano T, Ren J, Kharbanda S, and Kufe D (2009) MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor. Cancer Res 69:7013-7021.
2. Ahmad R, Rajabi H, Kosugi M, Joshi MD, Alam M, Vasir B, Kawano T, Kharbanda S, and Kufe D (2011) MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop. Sci Signal 4: ra9.
3. Croce MV, Isla-Larrain MT, Rua CE, Rabassa ME, Gendler SJ, and Segal-Eiras A (2003) Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer. J Histochem Cytochem 51:781-788. (Pubitemid 36628859)
4. Huang L, Chen D, Liu D, Yin L, Kharbanda S, and Kufe D (2005) MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res 65:10413-10422. (Pubitemid 41743735)
5. Jin C, Rajabi H, and Kufe D (2010) miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death. Int J Oncol 37:61-69.
6. Joshi MD, Ahmad R, Yin L, Raina D, Rajabi H, Bubley G, Kharbanda S, and Kufe D (2009) MUC1 oncoprotein is a druggable target in human prostate cancer cells. Mol Cancer Ther 8:3056-3065.
7. Khodarev N, Ahmad R, Rajabi H, Pitroda S, Kufe T, McClary C, Joshi MD, Mac-Dermed D, Weichselbaum R, and Kufe D (2010) Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Oncogene 29:920-929.
8. Khodarev NN, Pitroda SP, Beckett MA, MacDermed DM, Huang L, Kufe DW, and Weichselbaum RR (2009) MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer. Cancer Res 69:2833-2837.
9. Kim JS, Eom JI, Cheong JW, Choi AJ, Lee JK, Yang WI, and Min YH (2007) Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clin Cancer Res 13:1019-1028.
10. Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9:874-885.
11. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, and Schlom J (1984) Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3:223-232. (Pubitemid 15184701)
12. Lee WJ, Chen WK, Wang CJ, Lin WL, and Tseng TH (2008) Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 226:178-191.
13. Leng Y, Cao C, Ren J, Huang L, Chen D, Ito M, and Kufe D (2007) Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J Biol Chem 282:19321-19330. (Pubitemid 47100108)
14. Li Y, Liu D, Chen D, Kharbanda S, and Kufe D (2003) Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 22:6107-6110. (Pubitemid 37175889)
15. Long X, Fan M, Bigsby RM, and Nephew KP (2008) Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Mol Cancer Ther 7:2096-2108.
16. MacDermed DM, Khodarev NN, Pitroda SP, Edwards DC, Pelizzari CA, Huang L, Kufe DW, and Weichselbaum RR (2010) MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients. BMC Medical Genomics 3:16.
17. Meyer H, Bolarinwa A, Wolfram G, and Linseisen J (2006) Bioavailability of apige-nin from apiin-rich parsley in humans. Ann Nutr Metab 50:167-172. (Pubitemid 43829804)
18. Patel D, Shukla S, and Gupta S (2007) Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol 30:233-245.
19. Perey L, Hayes DF, Maimonis P, Abe M, O'Hara C, and Kufe DW (1992) Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 52:2563-3568.
20. Pitroda SP, Khodarev NN, Beckett MA, Kufe DW, and Weichselbaum RR (2009) MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment. Proc Natl Acad Sci USA 106:5837-5841.
21. Raina D, Ahmad R, Joshi MD, Yin L, Wu Z, Kawano T, Vasir B, Avigan D, Khar-banda S, and Kufe D (2009) Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res 69:5133-5141.
22. Raina D, Kharbanda S, and Kufe D (2004) The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J Biol Chem 279:20607-20612. (Pubitemid 38656454)
23. Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, and Kufe D (2007) The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 27:992-1004. (Pubitemid 47488189)
24. Ren J, Agata N, Chen D, Li Y, Yu WH, Huang L, Raina D, Chen W, Kharbanda S, and Kufe D (2004) Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 5:163-175. (Pubitemid 38283802)
25. Ren J, Bharti A, Raina D, Chen W, Ahmad R, and Kufe D (2006) MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene 25:20-31. (Pubitemid 43050000)
26. Shukla S and Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962-978.
27. Siddique YH and Afzal M (2009) Antigenotoxic effect of apigenin against mitomycin C induced genotoxic damage in mice bone marrow cells. Food Chem Toxicol 47:536-539.
28. Silvan S, Manoharan S, Baskaran N and Singh AK (2010) Apigenin: a potent antigenotoxic and anticlastogenic agent. Biomed Pharmacother doi:10/1016/j.biopha.2010.08.005.
29. Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, and Sakai T. (2008) Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res 68:8918-8927.
30. Way TD, Kao MC, and Lin JK (2004) Apigenin induces apoptosis through protea-somal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 279:4479-4489.
31. Way TD, Kao MC, and Lin JK (2005) Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett 579:145-152.
32. Wei X, Xu H, and Kufe D (2005) Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 7:167-178. (Pubitemid 40248342)
33. Wei X, Xu H, and Kufe D (2006) MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol Cell 21:295-305. (Pubitemid 43099944)
34. Yin L, Kharbanda S, and Kufe D (2007) Mucin 1 oncoprotein blocks hypoxia-inducible factor 1alpha activation in a survival response to hypoxia. J Biol Chem 282:257-266. (Pubitemid 47076647)
35. Yin L, Kharbanda S, and Kufe D (2009) MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation. Int J Oncol 34:1691-1699.